Our Team
GenoCure.AI is built on the foundation of scientific excellence, business acumen, and technological innovation. Our diverse team brings together world-leading researchers, experienced entrepreneurs, and visionary advisors, all united by a shared mission: revolutionizing precision oncology through AI-driven insights.
Leadership Team
Eitan Rubinow
LL.B., M.B.A
Chief Executive Officer & Co-founder
Eitan Rubinow LL.B., M.B.A
Chief Executive Officer & Co-founder
Eitan Rubinow is an accomplished entrepreneur and business strategist with two decades of experience in executive leadership roles. With degrees in law and economics, as well as a master’s in business administration, he brings a multidisciplinary approach to driving GenoCure.AI’s strategic growth. Throughout his career, he has led large-scale operations, optimized corporate structures, and spearheaded high-impact business initiatives. His expertise spans company scaling, operational efficiency, and investment strategy, positioning the company as a innovative force in the pharmaceutical and clinical research industries. Holding a license to practice law, he leverages his deep understanding of regulatory frameworks and business law to navigate the complexities of the biotech sector while ensuring sustainable expansion.
Prof. Shai Rosenberg
M.D., Ph.D.
Chief Technology Officer, Chief Scientific Officer & Co-founder
Prof. Shai Rosenberg M.D., Ph.D.
Chief Technology Officer, Chief Scientific Officer & Co-founder
Prof. Rosenberg is a physician-scientist specializing in neuro-oncology. With an MD and advanced clinical training in oncology, he combines hands-on medical expertise with a deep research focus. His work in computational biology, backed by a Ph.D., enables him to integrate AI-driven approaches into oncology. At Hadassah Medical Center, he leads multiple key initiatives, serving as Head of the Unit for AI in Oncology, Head of the Laboratory of Computational Biology of Cancer, and Head of the Sagol Program for Computational Biology and Medicine. His extensive experience in multi-omics data analysis and precision oncology has been instrumental in driving advancements in cancer treatment. At GenoCure.AI, he ensures that Supreme™ remains at the forefront of innovation, bridging cutting-edge computational research with real-world clinical applications.
Dr. Eitan Eliram
Ph.D
Chief Product Officer, VP Business Development & Co-founder
Dr. Eliram is an accomplished entrepreneur with extensive experience in launching and scaling technology-driven ventures. Bringing 25 years of expertise in both business development and technology, he has played a pivotal role in transforming innovative concepts into successful enterprises. Before co-founding GenoCure.AI, Dr. Eliram held leadership positions in multiple startups, where he was instrumental in securing strategic partnerships, driving commercialization strategies, and expanding market reach. He holds a Ph.D. in digital communication, further strengthening his ability to navigate the intersection of technology and business. His ability to bridge cutting-edge research with industry needs makes him a key force in ensuring GenoCure.AI’s growth, business strategy, and long-term impact in precision oncology.
Advisory Board
Prof. Carlos Caldas
M.D., Ph.D.
Prof. Carlos Caldas M.D., Ph.D.
A distinguished researcher from the University of Cambridge, Prof. Caldas is a global authority in breast cancer genomics and precision medicine. His pioneering work focuses on understanding the molecular landscape of breast cancer, leading to improved classification, prognosis, and personalized treatment strategies. His expertise in translational oncology ensures that cutting-edge genomic discoveries are effectively integrated into clinical practice. Beyond his research, Prof. Caldas is deeply embedded in the global oncology community, maintaining strong connections with leading research institutions, pharmaceutical companies, and regulatory bodies. At GenoCure.AI’s Advisory Board, he plays a crucial role in refining predictive models for combination therapies, leveraging his extensive experience and network to enhance Supreme™‘s analytical capabilities and drive collaborations that accelerate clinical adoption.
Prof. Aron Popovtzer
M.D.
Prof. Aron Popovtzer M.D.
Prof. Popovtzer is the Director of the Oncology Division at Hadassah Medical Center, a leading authority in cancer treatment and radiation therapy. A world-renowned expert in head and neck oncology, he has significantly advanced the integration of precision medicine in radiotherapy. His research focuses on biomarker discovery, targeted therapies, and the optimization of radiation treatment through AI and advanced imaging. In addition to his scientific expertise, Prof. Popovtzer maintains strong relationships across the oncology ecosystem, collaborating with leading medical centers, industry innovators, and policymakers. At GenoCure.AI’s Advisory Board, he plays a pivotal role in ensuring that Supreme™’s analytical frameworks translate into clinically actionable insights, particularly in the personalization of radiotherapy. His extensive network enables GenoCure.AI to gain access to top-tier clinical trials, regulatory channels, and institutional collaborations that drive innovation from research to patient care.
Research Team
Efrat Shapira
MSc
Researcher
Efrat Shapira MSc
Researcher
A rising star in computational oncology, Shapira is a key contributor to GenoCure.AI’s research initiatives. Her expertise in advanced analytics and AI-driven biomarker discovery reinforces the company’s commitment to groundbreaking scientific advancements.